Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 31(3):314-320;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23233710
- PMC
- PMC3732010
- Study Number(s)
- S0016
A phase III randomized intergroup trial of CHOP chemotherapy plus rituximab compared to CHOP chemotherapy plus 131iodine-tositumomab for previously untreated follicular non-hodgkins lymphoma (SWOG S0016)
- Journal / Conference
- Journal of Clinical Oncology 31(3):337-343;
- Year
- 2013
- Research Committee(s)
- Brain
- PMID
- PMID23071247
- PMC
- PMC3732012
A phase 3 trial of chemotherapy for anaplastic oligodendroglioma: long-terms results of RTOG 9402
- Journal / Conference
- PlosOne 8(8):e70812;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID23967110
- PMC
- PMC3743845
- Study Number(s)
- SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500
The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia
- Journal / Conference
- British Journal of Cancer 109(7):1744-1749
- Year
- 2013
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24022189
- PMC
- PMC3790171
- Study Number(s)
- S0030
Higher area under the curve and reduced capecitabine clearance in elderly patients with advanced colorectal cancer (SWOG 0030)
- Journal / Conference
- Annals of Oncology 24(7):1754-1761;
- Year
- 2013
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID23524864
- PMC
- PMC3690906
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
- Journal / Conference
- Leukemia 27(1):238-241;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID22722750
- PMC
- PMC4457316
- Study Number(s)
- SWOG-9031, SWOG-9333
Mutations in the DNMT3A exon 23 independently predict poor outcome in older AML patients: a SWOG report [Letter to the Editor]
- Journal / Conference
- Journal of Urology 190(4):1200-1204;
- Year
- 2013
- Research Committee(s)
- Genitourinary
- PMID
- PMID23597452
- PMC
- PMC4113593
- Study Number(s)
- S0353
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with non-muscle invasive bladder cancer who recurred following at least two prior courses of bacillus Calmette-Guérin
- Journal / Conference
- Journal of Clinical Oncology 31(6):692-700;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23182984
- PMC
- PMC3574267
- Study Number(s)
- E2496
Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced stage classical hodgkin lymphoma
- Journal / Conference
- Journal of Clinical Oncology 31(6):684-691;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23182987
- PMC
- PMC3574266
- Study Number(s)
- E2496
A randomized phase III trial of ABVD vs. Stanford V +/- radiation therapy in locally extensive and advanced stage hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)
- Journal / Conference
- Cancer 119(23):4170-4179;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID24104597
- PMC
- PMC3833872
- Study Number(s)
- S0106, SWOG-8600, SWOG-9500